Litcius/Paper detail

Cell-intrinsic PD-L1 ablation sustains effector CD8+ T cell responses and promotes antitumor T cell therapy

Xinran Wang, Lu Lu, Xiaochuan Hong, Lingling Wu, Chao Yang, You Wang, Wenwen Li, Yuanqin Yang, Dongqing Cao, Wen Di, Liufu Deng

2024Cell Reports19 citationsDOIOpen Access PDF

Abstract

Publisher of over 50 scientific journals across the life, physical, earth, and health sciences, both independently and in partnership with scientific societies including Cell, Neuron, Immunity, Current Biology, AJHG, and the Trends Journals.

Topics & Concepts

EffectorIntracellularCD8Programmed cell deathImmunotherapyCellT cellCell biologyCytotoxic T cellAdoptive cell transferPD-L1Cancer researchCell therapyChemistryBiologyImmunologyImmune systemApoptosisBiochemistryIn vitroCAR-T cell therapy researchCancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cell-intrinsic PD-L1 ablation sustains effector CD8+ T cell responses and promotes antitumor T cell therapy | Litcius